Article Details

AstraZeneca Antisense Medicine Met Its Primary, Secondary Goals To Lower Cholesterol - Benzinga

Retrieved on: 2022-04-04 14:16:53

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Antisense Medicine Met Its Primary, Secondary Goals To Lower Cholesterol - Benzinga. View article details on hiswai:

Excerpt

Ionis Pharmaceuticals Inc (NASDAQ: IONS) and its partner, AstraZeneca Plc (NASDAQ: AZN), have.

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up